Pmv Pharmaceuticals, Inc.
PMVP
Revenue
0.00
0.000.00%
-Assets
237.54M
▲663.00k▲0.2799%
3 Months ChangeLiabilities
23.22M
▼-976.00k▼-4.03%
3 Months ChangeFree Cash Flow
-16.19M
▼-1.02M▼-6.74%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-08
Form 10-Q
ID: 0000950170-24-093343
2024-08-08
Form 8-K
ID: 0000950170-24-093345
2024-06-07
Form 8-K
ID: 0001193125-24-156745
2024-05-09
Form 10-Q
ID: 0000950170-24-056295
2024-05-09
Form 8-K
ID: 0000950170-24-056294
2024-02-29
Form 8-K
ID: 0000950170-24-023058
2024-01-18
Form 8-K
ID: 0001193125-24-010177
2024-01-05
Form 8-K
ID: 0001193125-24-003348
2023-11-09
Form 10-Q
ID: 0000950170-23-061551
2023-11-09
Form 8-K
ID: 0000950170-23-061552